Aralast NP
STN: 125039
Proper Name: Alpha1-Proteinase Inhibitor (Human)
Tradename: Aralast NP
Manufacturer: Baxter Healthcare Corp, License #0140
Indication:
- Indicated for chronic augmentation therapy in patients having congenital deficiency with clinically evident emphysema.
Product Information
Supporting Documents
Related Information
- FDA Online Label Repository
Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.